Mydecine

The Scoop on Mydecine’s Novel Drug Compounds

Apr 14, 2021

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Apr 13, 2021

TDR’s Top 5 Psychedelic Developments For The Week Of April 5

Apr 10, 2021

Mydecine Announces API-naming structure of Four Lead Candidates and Prepares for Pre-IND

Apr 7, 2021

CSO Rob Roscow: Transforming Research From Mydecine’s 3 Pillars Into Repeatable Medicine

Mar 23, 2021

Mydecine Innovations Group Announces Migration to NEO Exchange

Mar 23, 2021

Mydecine Innovations Group Provides Update on European Operations

Mar 16, 2021

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Mar 10, 2021

Mydecine Co-Founder Damon Michaels: It’s Time To Make Alternative Medicine Modern Medicine

Mar 9, 2021

Mydecine Innovations’ Josh Bartch: The Last 12 Months Have Been Monumental For The Industry

Mar 4, 2021